Related Experiment Video

Updated: May 21, 2026

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

Picolinic acid in patients with chronic hepatitis C infection: a preliminary report

Jolanta Zuwała-Jagiello1, Monika Pazgan-Simon, Krzysztof Simon

  • 1Department of Pharmaceutical Biochemistry, Wroclaw Medical University, Poland. jagiellodr@interia.pl

Mediators of Inflammation
|June 16, 2012
PubMed

Insights

Picolinic acid (PA) levels are elevated in chronic hepatitis C (CHC) patients, reflecting increased inflammation. Higher PA and hsCRP levels in CHC patients with diabetes suggest a link between diabetes, inflammation, and PA in liver disease.

Area of Science:

  • Immunology
  • Hepatology
  • Metabolic Diseases

Background:

  • Macrophage activation is implicated in chronic liver diseases.
  • Picolinic acid (PA) activates macrophages and promotes inflammatory responses.
  • Activated macrophages are involved in chronic viral hepatitis inflammation.

Purpose of the Study:

  • To determine serum PA levels in patients with chronic hepatitis C (CHC) infection.
  • To investigate the influence of diabetes on PA levels in CHC patients.
  • To assess the relationship between PA, inflammation (hsCRP), and diabetes in CHC.

Main Methods:

  • Serum PA and hsCRP levels were measured in 51 CHC patients (with and without diabetes) and 40 controls.
  • Statistical analysis was used to compare groups and identify relationships.

Main Results:

  • CHC patients exhibited significantly higher plasma PA and hsCRP levels than controls.
  • PA and hsCRP levels were more elevated in CHC patients with diabetes compared to those without.
  • Positive correlations were found between PA and hsCRP, and between PA and diabetes presence.

Conclusions:

  • Elevated serum PA levels are associated with increased inflammation (hsCRP) in CHC patients.
  • Diabetes prevalence is linked to higher serum PA levels in CHC patients.
  • PA may serve as a biomarker for inflammation and diabetes in chronic liver disease.

More Related Videos

Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model08:20

Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model

Published on: December 2, 2022

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Concept Videos

Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...